Core Viewpoint - A lawsuit is pending against Manhattan Associates, Inc. for alleged violations of securities laws, with claims that the company misled investors regarding its revenue outlook and growth potential [2]. Group 1: Lawsuit Details - The lawsuit was filed by an investor on February 25, 2025, alleging that Manhattan Associates made false and misleading statements about its financial health and growth prospects [2]. - The plaintiff claims that the company created a false impression of having reliable information about its projected revenue and growth while downplaying risks associated with seasonality and macroeconomic fluctuations [2]. - It is asserted that the company's optimistic reports on growth in its professional services did not align with the actual performance, particularly in light of macroeconomic challenges [2]. Group 2: Investor Information - Shareholders who purchased shares of Manhattan Associates prior to October 2024 and continue to hold them are encouraged to contact the Shareholders Foundation for options regarding the lawsuit [1][3]. - The Shareholders Foundation provides services related to shareholder issues, including information on securities class actions and legal news relevant to the financial market [3].

SAN DIEGO, April 30, 2025 /PRNewswire/ -- Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM).Investors who purchased shares of Actinium Pharmaceuticals, Inc. (NYSE: ATNM) prior to October 2022 and continue to hold any of thoseNYSE: ATNM shares also have certain options and contact the Shareholders Foundation at [email protected] or call +1(858) 779 - 1554.On March 27, 2025, aNYSE: ATNM investor filed a lawsuit agai ...